Adenoviruses as gene-delivery vectors took a hit 20 years ago ... With their 2022 start-up Vector Biopharma, Andreas Plückthun of the University of Zurich and serial pharmaceutical executive ...

airway clearance has been used in AAV clinical trials to increase vector delivery to the lung. Eight-week old IL-10-deficient transgenic (IL-10T) mice (C57BL/6 background) were purchased from the ...

These viruses can also trigger dangerous immune responses. Vector BioPharma is taking a different approach with a delivery vehicle that’s like a virus, but devoid of the features that limit ...

As soon as the genetic sequence of SARS-CoV-2 was posted online in January, three groups began independently working on adenoviral vector vaccines for COVID-19: CanSino Biologics, the University ...

The campus will also house a research institution dedicated to developing new gene delivery techniques, vector-based vaccines, virus-based cancer therapeutics, and training for scientists and ...